Durak I, Güven T, Birey M, Oztürk H S, Kurtipek O, Yel M, Dikmen B, Canbolat O, Kavutcu M, Kaçmaz M
Department of Biochemistry, Ankara University, Medical Faculty, Turkey.
Can J Anaesth. 1996 Jul;43(7):741-8. doi: 10.1007/BF03017960.
The aim of this study was to investigate the relation between halothane hepatotoxicity and hepatic free radical metabolism and to establish a possible protective role of vitamin E against halothane hepatotoxicity.
Twenty-eight guinea pigs were used in the experiments. Halothane (1.5% v/v) in oxygen (100%) was given to the animals for 90 min over three days. Livers from animals were then taken and prepared for the assays. In the enzymatic study, superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT) activities were measured. As a peroxidation index, the malondialdehyde (MDA) concentration was determined. Also, electron spin resonance (ESR) analysis and electron microscopy (EM) were performed.
Superoxide dismutase (1168.3 +/- 78.2 U.mg-1) and glutathione peroxidase (14.9 +/- 6.2 mIU.mg-1) activities were decreased, but catalase activity (1260.0 +/- 250.6 IU.mg-1) and malondialdehyde concentration (11.5 +/- 1.8 ppb) were increased in liver tissues exposed to halothane compared with control values (1382.2 +/- 91.8 U.mg-1 for SOD, 27.8 +/- 5.2 mIU.mg-1 for GSH-Px, 840.2 +/- 252.4 IU.mg-1 for CAT and 10.0 +/- 1.0 ppb for MDA). Electron spin resonance analysis revealed a peak of CF3CHCl. radical in the exposed tissue. Electron microscopy indicated ultrastructural changes in the hepatic cells of both halothane groups with and without vitamin E treatment.
Halothane causes impairment in the hepatic antioxidant defense system and accelerates peroxidation reactions. As a result, some ultrastructural changes in hepatic tissues occur due to halothane treatment. Although vitamin E prevents peroxidative damage, it does not ameliorate ultrastructural changes caused by halothane treatment. This shows that halothane toxicity results not only from impaired hepatic antioxidant defense system but also from other, unknown causes.
本研究旨在探讨氟烷肝毒性与肝脏自由基代谢之间的关系,并确定维生素E对氟烷肝毒性可能的保护作用。
实验使用28只豚鼠。在三天内,让动物吸入含1.5%(体积/体积)氟烷的纯氧90分钟。然后取出动物的肝脏并准备进行检测。在酶学研究中,测量超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)和过氧化氢酶(CAT)的活性。作为过氧化指标,测定丙二醛(MDA)浓度。此外,还进行了电子自旋共振(ESR)分析和电子显微镜(EM)检查。
与对照组相比(SOD为1382.2±91.8 U.mg-1,GSH-Px为27.8±5.2 mIU.mg-1,CAT为840.2±252.4 IU.mg-1,MDA为10.0±1.0 ppb),暴露于氟烷的肝脏组织中,超氧化物歧化酶(1168.3±78.2 U.mg-1)和谷胱甘肽过氧化物酶(14.9±6.2 mIU.mg-1)活性降低,但过氧化氢酶活性(1260.0±250.6 IU.mg-1)和丙二醛浓度(11.5±1.8 ppb)升高。电子自旋共振分析显示,暴露组织中有CF3CHCl·自由基峰。电子显微镜检查表明,在接受或未接受维生素E治疗的两个氟烷组的肝细胞中均出现超微结构变化。
氟烷会损害肝脏抗氧化防御系统并加速过氧化反应。结果,氟烷处理导致肝脏组织出现一些超微结构变化。虽然维生素E可防止过氧化损伤,但它并不能改善氟烷处理引起的超微结构变化。这表明氟烷毒性不仅源于肝脏抗氧化防御系统受损,还源于其他未知原因。